| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |